Shareholding2 Sept 2026, 05:10 pm
Mirae Asset Mutual Fund Acquires 5.44% Stake in Symbiotec Pharmalab
AI Summary
Mirae Asset Mutual Fund has acquired a 5.44% stake in Symbiotec Pharmalab Ltd through open market purchases. The acquisition, which took place on September 1, 2026, increased Mirae Asset's total holding in the company to 6.22%. The total equity share capital of Symbiotec Pharmalab before the acquisition was ₹64,256,112, and after the acquisition, it remains the same, with the total diluted share capital also at ₹64,318,172. This disclosure is made under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Highlights
- Mirae Asset Mutual Fund acquired 5.44% stake in Symbiotec Pharmalab.
- Total holding by Mirae Asset now stands at 6.22%.
- Acquisition was made via open market purchases.
- Transaction date was September 1, 2026.
- Disclosure filed under SEBI Takeover Regulations.
Price Impact
More from SYMBIOTEC